WEDNESDAY, Jan. 26, 2022 (HealthDay News) — A one-two punch from science has clearly tagged the mononucleosis virus, Epstein-Barr, as a major cause of multiple sclerosis. The Epstein-Barr virus (EBV) appears to trigger multiple sclerosis (MS) by tricking the immune systems of some into attacking their body’s own nerve cells,Continue Reading
TUESDAY, Jan. 25, 2022 (HealthDay News) – Older adults who maintain a steady weight as they age are less likely to experience rapid cognitive decline, regardless of how much they weigh to start, new research suggests. “There’s something about maintaining weight and BMI that seems to reflect some health resilience,”Continue Reading
MONDAY, Jan. 24, 2022 (HealthDay News) — The coronavirus can leave more than 40% of children hospitalized for COVID-19 with headaches and other lingering neurological symptoms, a new study claims. And the kids who developed these headaches or experienced an altered mental status known as acute encephalopathy were more likelyContinue Reading
MONDAY, Jan. 24, 2022 (HealthDay News) — A brain implant that helps control severe epilepsy in adults may do the same for children who suffer from unrelenting seizures, new research suggests. The study is one of the first to examine the responsive neurostimulation (RNS) system in children. RNS has alreadyContinue Reading
MONDAY, Jan. 24, 2022 (HealthDay News) — When American kids do downhill skiing or snowboarding, they almost always wear a helmet, their parents say, but they’re far less likely to do so when cruising down a neighborhood hill on a sled. That puts them at risk for serious head injuries,Continue Reading
FRIDAY, Jan. 21, 2022 (HealthDay News) — If you or someone you know has suffered a concussion, a medical evaluation is crucial, an expert says. A concussion is “a short-lived functional brain injury typically caused by a bump or blow to the head,” Cleveland Clinic concussion specialist Dr. Richard FiglerContinue Reading
THURSDAY, Jan. 20, 2022 (HealthDay News) — Brain fog. It has become an inexplicable side effect of COVID-19 infection, but researchers now report they have discovered a possible reason why it happens. In a small study, investigators found abnormalities in the cerebrospinal fluid of some COVID-19 patients who developed thinkingContinue Reading
FRIDAY, Jan. 14, 2022 (HealthDay News) — Everyone knows cleaner air means healthier bodies, but new research suggests it might also help aging minds. “Our study is important because it is one of the first to show that reducing air pollution over time may benefit the brain health of olderContinue Reading
THURSDAY, Jan. 13, 2022 (HealthDay News) — A few hours of exercise a week may help slow Parkinson’s disease, even if it’s just moderate activity such as walking or gardening, a new study suggests. The key is to be consistent, the researchers found. “Although medications can provide people with Parkinson’sContinue Reading
TUESDAY, Jan. 11, 2022 (HealthDay News) — It’s a move that could severely limit the number of people taking the controversial new Alzheimer’s drug Aduhelm: Medicare on Tuesday proposed to only cover the cost of the pricey medication for people enrolled in approved clinical trials. A final decision on coverageContinue Reading
TUESDAY, Jan. 11, 2022 (HealthDay News) — For several years, a leading U.S. pediatricians’ group has called for middle and high schools to start later in the morning, to help these young people get the right amount of sleep. Now, new research suggests that students aren’t the only ones whoContinue Reading
MONDAY, Jan. 10, 2022 (HealthDay News) — Exercise helps you stay fit, hale and hearty, and researchers say it may also help you stave off dementia and Alzheimer’s disease. Now they have a better understanding of the hidden benefits that aid the brain. Older folks who are more physically activeContinue Reading
FRIDAY, Jan. 7, 2022 (HealthDay News) — Following a months-long and unprecedented review, Medicare officials expect to announce within the next couple of weeks whether the program will cover the controversial Alzheimer’s drug Aduhelm. The drug’s benefits are in question and its annual price tag tops $28,000. The U.S. CentersContinue Reading
THURSDAY, Jan. 6, 2022 (HealthDay News) — A medication that acts on certain brain receptors can temporarily ease visual-processing problems in some adults with autism, a small study has found. Researchers said it’s far too early to know whether the drug, arbaclofen, could prove useful in managing those visual issues.Continue Reading